Sanofi 2nd quarter profit surges


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

PARIS (AP) — French drug maker Sanofi said Thursday its earnings soared in the second quarter thanks to lower accounting charges than a year earlier, and the company lifted it full-year profit forecast.

Sanofi reported net profit of 777 million euros ($1.04 billion) in the second quarter, up from 448 million euros a year earlier, when earnings were hit with a 430 million euro accounting charge related to terminating the iniparib cancer treatment program.

Sanofi Chief Executive Chris Viehbacher said the group's late-stage drug pipeline displayed "strong momentum" and that Sanofi is preparing "for a wave of new product launches".''

Sanofi forecast growth in what it calls "Business EPS" of between 6 and 8 percent this year. In February it said growth by this measure would be 4 to 7 percent.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast